Oesophageal diameter is associated with severity but not progression of systemic sclerosis‐associated interstitial lung disease
ABSTRACT Background and objective It is unknown whether oesophageal disease is associated with systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) severity, progression or mortality. Methods High‐resolution computed tomography (HRCT) scans from 145 SSc‐ILD patients were scored for fibr...
Gespeichert in:
Veröffentlicht in: | Respirology (Carlton, Vic.) Vic.), 2018-10, Vol.23 (10), p.921-926 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | ABSTRACT
Background and objective
It is unknown whether oesophageal disease is associated with systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) severity, progression or mortality.
Methods
High‐resolution computed tomography (HRCT) scans from 145 SSc‐ILD patients were scored for fibrosis score, oesophageal diameter and presence of hiatal hernia. Fibrosis asymmetry was calculated as: (most affected side − least affected side)/(most affected side + least affected side). Mixed effects models were used for repeated measures analyses.
Results
Mean fibrosis score was 8.6%, and most patients had mild‐to‐moderate physiological impairment. Every 1 cm increase in oesophageal diameter was associated with 1.8% higher fibrosis score and 5.5% lower forced vital capacity (FVC; P ≤ 0.001 for unadjusted and adjusted analyses). Patients with hiatal hernia had 3.9% higher fibrosis score, with persistent differences on adjusted analysis (P = 0.001). Oesophageal diameter predicted worsening fibrosis score over the subsequent year (P = 0.02), but not when adjusting for baseline fibrosis score (P = 0.16). Oesophageal diameter was independently associated with mortality (P = 0.001). Oesophageal diameter was not associated with asymmetric disease or radiological features of gross aspiration.
Conclusion
Oesophageal diameter and hiatal hernia are independently associated with SSc‐ILD severity and mortality, but not with ILD progression or asymmetric disease. Oesophageal disease is unlikely to be a significant driver of ILD progression in SSc.
We used a large cohort of patients with systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) to conduct the most comprehensive study to date evaluating the association of oesophageal measures with progression and mortality of SSc‐ILD. We show that oesophageal disease is associated with SSc‐ILD severity and mortality, but not with ILD progression or asymmetry.
See related Editorial |
---|---|
ISSN: | 1323-7799 1440-1843 |
DOI: | 10.1111/resp.13309 |